Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay.
Koeks Z, Janson AA, Beekman C, Signorelli M, van Duyvenvoorde HA, van den Bergen JC, Hooijmans MT, Alleman I, Hegeman IM, Verschuuren JJGM, V Deutekom JC, Spitali P, Datson NA, Niks EH. Koeks Z, et al. Among authors: signorelli m. Sci Rep. 2021 Mar 15;11(1):5952. doi: 10.1038/s41598-021-84863-w. Sci Rep. 2021. PMID: 33723284 Free PMC article.
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy.
Signorelli M, Ayoglu B, Johansson C, Lochmüller H, Straub V, Muntoni F, Niks E, Tsonaka R, Persson A, Aartsma-Rus A, Nilsson P, Al-Khalili Szigyarto C, Spitali P. Signorelli M, et al. J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):505-517. doi: 10.1002/jcsm.12517. Epub 2019 Dec 27. J Cachexia Sarcopenia Muscle. 2020. PMID: 31881125 Free PMC article.
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.
Strandberg K, Ayoglu B, Roos A, Reza M, Niks E, Signorelli M, Fasterius E, Pontén F, Lochmüller H, Domingos J, Ala P, Muntoni F, Aartsma-Rus A, Spitali P, Nilsson P, Szigyarto CA. Strandberg K, et al. Among authors: signorelli m. J Neuromuscul Dis. 2020;7(3):231-246. doi: 10.3233/JND-190454. J Neuromuscul Dis. 2020. PMID: 32390640 Free PMC article.
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy.
Previtali SC, Gidaro T, Díaz-Manera J, Zambon A, Carnesecchi S, Roux-Lombard P, Spitali P, Signorelli M, Szigyarto CA, Johansson C, Gray J, Labolle D, Porte Thomé F, Pitchforth J, Domingos J, Muntoni F. Previtali SC, et al. Among authors: signorelli m. Pharmacol Res. 2020 Sep;159:104999. doi: 10.1016/j.phrs.2020.104999. Epub 2020 Jun 12. Pharmacol Res. 2020. PMID: 32535224 Free PMC article. Clinical Trial.
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients.
Signorelli M, Ebrahimpoor M, Veth O, Hettne K, Verwey N, García-Rodríguez R, Tanganyika-deWinter CL, Lopez Hernandez LB, Escobar Cedillo R, Gómez Díaz B, Magnusson OT, Mei H, Tsonaka R, Aartsma-Rus A, Spitali P. Signorelli M, et al. EMBO Mol Med. 2021 Apr 9;13(4):e13328. doi: 10.15252/emmm.202013328. Epub 2021 Mar 10. EMBO Mol Med. 2021. PMID: 33751844 Free PMC article.
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinineratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy.
van de Velde NM, Koeks Z, Signorelli M, Verwey N, Overzier M, Bakker JA, Sajeev G, Signorovitch J, Ricotti V, Verschuuren J, Brown K, Spitali P, Niks EH. van de Velde NM, et al. Among authors: signorelli m. Neurology. 2023 Feb 28;100(9):e975-e984. doi: 10.1212/WNL.0000000000201609. Epub 2022 Dec 5. Neurology. 2023. PMID: 36849458 Free PMC article.
323 results